Expanded Surveillance for Pediatric Infectious Diseases
Centers for Disease Control and Prevention - ERA · Department of Health and Human Services
At a glance
Expanded Surveillance for Pediatric Infectious Diseases is a forecasted federal cooperative agreement opportunity from the Centers for Disease Control and Prevention - ERA (Department of Health and Human Services). The agency's forecast estimates an application due date of December 31, 2026; forecast dates can change. Individual awards are listed as $850K – $1.14M, with about 7 awards expected and $40M in total estimated funding. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 8 more. Cost sharing is not required. It is funded under Assistance Listing 93.083 (Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Jul 28, 2026Forecast posted
- Oct 30, 2026 (est.)Full notice expectednext date
- Dec 31, 2026 (est.)Application deadline
- Jul 30, 2027 (est.)Est. award date
- Posted
- Jul 28, 2026
- Est. close date
- Dec 31, 2026
- Est. award date
- Jul 30, 2027
- Award floor
- $850,000
- Award ceiling
- $1,140,000
- Est. total funding
- $40,000,000
- Expected awards
- 7
- Cost sharing
- Not required
- Funding instrument
- Cooperative Agreement
- Opportunity category
- Discretionary
- Fiscal year
- FY2027
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- For-profit organizations (not small businesses)
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare.
In addition, the network will generate robust estimates of the effectiveness of influenza, rotavirus, respiratory syncytial virus (RSV) and other prevention products against respiratory and enteric viral illnesses in this population.
Recipients will identify AGE and ARI illnesses among patients seeking healthcare or diagnostic testing for acute illness among inpatient and emergency department populations. Recipients may also include patients seeking care in outpatient clinics, such as urgent care centers, as an optional activity.
This is a multi-component NOFO. You must apply for ComponentA (Core Component). You may also apply for one or more optional components.
Component A – Core Component (Required)
- Support inpatient and emergency department pediatric surveillance
- Follow the standardized protocol established by CDC
Optional Components
- Component B: Support outpatient pediatric surveillance
- Component C: Study immune response and infection
- Component D: Study immune response and immunization
Recipients will enroll patients meeting standard symptom criteria and confirm viral infections using approved molecular assays. The network will use the data to estimate prevention product effectiveness, hospitalization rates, and information on the natural history of medically attended diseases.
Findings of this NOFO will:
- Improve best practices for diagnosis and treatment protocols
- Inform prevention product recommendations
- Guide public health strategies
- Reduce viral illness-associated hospitalizations and healthcare utilization among children
How to apply
0 of 8 done · progress saved in this browser
Assistance Listing
What is an ALN?Reported obligations under ALN 93.083
Historical data · not a predictionAgency contact (as published)
Jamal Bankhead
JBankhead@cdc.gov
404-718-4108
Quick answers
Is “Expanded Surveillance for Pediatric Infectious Diseases” open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around October 30, 2026. Forecast details and dates can change.
Who is eligible to apply for “Expanded Surveillance for Pediatric Infectious Diseases”?
The official notice lists these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 1 more. Additional restrictions may apply; review the full notice.
How much funding is available through “Expanded Surveillance for Pediatric Infectious Diseases”?
Per the notice, individual awards are listed as $850k – $1.14m, total estimated program funding is $40,000,000 and the agency expects to make about 7 awards.
How do I apply for “Expanded Surveillance for Pediatric Infectious Diseases”?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-IP-27-035), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Centers for Disease Control and Prevention - ERA- Award range
- $1.75M – $6M
- Closes
- Nov 5, 2026
- Who can apply
- State governments, County governments, City or township governments and 10 more
State Occupational Safety and Health Surveillance Program (U60)
Centers for Disease Control and Prevention - ERA- Award range
- $150K – $685K
- Est. close
- Dec 30, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 4 more
Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network
Centers for Disease Control and Prevention - ERA- Award range
- $1.35M – $3.55M
- Est. close
- Dec 31, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 10 more
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Apr 5, 2027
- Who can apply
- Small businesses
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
Centers for Disease Control and Prevention - ERA- Award range
- Up to $550K
- Closes
- Dec 8, 2026
- Who can apply
- State governments, County governments, City or township governments and 12 more
US Travelers Health Research, Surveillance, Communication, and Outreach Network
Centers for Disease Control and Prevention - ERA- Award range
- $750K – $1M
- Closes
- Nov 5, 2026
- Who can apply
- State governments, County governments, City or township governments and 10 more